drugset / Trial / NCT01326117
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
NaSingle-groupOpen-labelTreatment
Summary
The investigators hypothesize that in adult patients with diabetic gastroparesis with Type 1 diabetes (HbA1c ≤ 10.5%), daily tadalafil use will significantly improve gastric emptying compared to baseline as measured by gastric emptying time.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tadalafil | Small molecule | 5 mg | — |